Every year, Fierce Healthcare's editorial team sifts through hundreds of nominations to identify 15 companies that are truly making waves in the healthcare sector, striving to change the world by changing the industry. The 2024 class of Fierce 15 honorees is no exception, taking on some of the most pressing challenges in healthcare today. 

This episode features a conversation with Fierce Healthcare's Paige Minemyer, Dave Muoio and Noah Tong. They share insights into this year's Fierce 15, discussing the companies that made the cut and the significant issues they are addressing.  

To learn more about the topics in this episode: 
Fierce Healthcare's Fierce 15 of 2024

Every year, Fierce Healthcare's editorial team sifts through hundreds of nominations to identify 15 companies that are truly making waves in the healthcare sector, striving to change the world by changing the industry. The 2024 class of Fierce 15 honorees is no exception, taking on some of the most pressing challenges in healthcare today. 
This episode features a conversation with Fierce Healthcare's Paige Minemyer, Dave Muoio and Noah Tong. They share insights into this year's Fierce 15, discussing the companies that made the cut and the significant issues they are addressing.  
To learn more about the topics in this episode: 
<ul>
<li><a href="https://www.fiercehealthcare.com/special-reports/fierce-healthcares-fierce-15-2024" data-cke-saved-href="https://www.fiercehealthcare.com/special-reports/fierce-healthcares-fierce-15-2024">Fierce Healthcare's Fierce 15 of 2024</a></li>
</ul>

Podnosis: the pulse of the healthcare industry. Every week, journalists from Fierce Healthcare dive into some of the industry’s biggest trends. We talk to the experts about what’s important now so you can prep for the future. Hear about all things healthcare, from physician practices to hospital chains and insurance giants—and those that mix all three—plus the tech they use, disruptors looking to compete and people moving the sector forward. Follow Podnosis on Apple Podcasts, Spotify, Amazon or wherever you get your podcasts.

Podnosis: the pulse of the healthcare industry. Every week, journalists from Fierce Healthcare dive into some of the industry’s biggest trends. We talk to the experts about what’s important now so you can prep for the future. Hear about all things healthcare, from physician practices to hospital chains and insurance giants—and those that mix all three—plus the tech they use, disruptors looking to compete and people moving the sector forward. Follow Podnosis on Apple Podcasts, Spotify, Amazon or wherever you get your podcasts.

Podnosis

Podnosis: the pulse of the healthcare industry. Every week, journalists from Fierce Healthcare dive into some of the industry’s biggest trends. We talk to the experts about what’s important now so you can prep for the future. Hear about all things healthcare, from physician practices to hospital chains and insurance giants—and those that mix all three—plus the tech they use, disruptors looking to compete and people moving the sector forward. Follow Podnosis on Apple Podcasts, Spotify, Amazon or wherever you get your podcasts.

The Fierce 15 of 2024

Consumer wearables are popular for a reason. People like to have their health data on demand. These insights can encourage healthy habits and may flag early signals of an underlying illness.

The problem is interpretability. Without a doctor’s input, many people are left to puzzle over their results and what they imply. Timely medical advice is important, yet often missing.

Reperio Health aims to address that gap. It combines at-home health screenings, an app and virtual clinical visits to help patients make sense of it all. Senior Writer Anastassia Gliadkovskaya sits down with Reperio’s co-founder and CEO, Travis Rush, to explain.

To learn more about the topics in this episode: 
At-home testing company Reperio teams up with Amazon One Medical on preventive care
Doctronic, Simple HealthKit partner to connect at-home screening with AI-powered clinical care
Noom launches at-home biomarker test kit for metabolic health monitoring 

Consumer wearables are popular for a reason. People like to have their health data on demand. These insights can encourage healthy habits and may flag early signals of an underlying illness.
The problem is interpretability. Without a doctor&rsquo;s input, many people are left to puzzle over their results and what they imply. Timely medical advice is important, yet often missing.
Reperio Health aims to address that gap. It combines at-home health screenings, an app and virtual clinical visits to help patients make sense of it all. Senior Writer Anastassia Gliadkovskaya sits down with Reperio&rsquo;s co-founder and CEO, Travis Rush, to explain.
To learn more about the topics in this episode:&nbsp;
<ul>
<li><a href="https://www.fiercehealthcare.com/providers/reperio-health-teams-amazon-one-medical-preventive-care" data-processed-url="true">At-home testing company Reperio teams up with Amazon One Medical on preventive care</a></li>
<li><a href="https://www.fiercehealthcare.com/ai-and-machine-learning/doctronic-simple-healthkit-partner-connect-home-screening-ai-powered" data-processed-url="true">Doctronic, Simple HealthKit partner to connect at-home screening with AI-powered clinical care</a></li>
<li><a href="https://www.fiercehealthcare.com/health-tech/noom-launches-home-biomarker-test-kit-metabolic-health-monitoring" data-processed-url="true">Noom launches at-home biomarker test kit for metabolic health monitoring</a>&nbsp;</li>
</ul>

Bringing preventive care into the home

Elevated medical costs and policy turmoil continued to affect the financial performance of payers and providers in the second quarter. Providers are still feeling the sting of fluctuations in ACA plan enrollment, while payers pointed to the No Surprises Act’s arbitration process as a major challenge.

Fierce Healthcare editor Dave Muoio and senior writer Paige Minemyer sit down for another deep dive into the biggest trends emerging from second-quarter earnings calls.

To learn more about the topics in this episode: 
Insurers see positive results in managing health costs in Q2
Ardent Health offsets Q2 volume stumble by tightening costs, renegotiating contracts
CVS enhances supports for patients taking GLP-1s
Universal Health Services tops Q2 expectations, but dials back full-year earnings
Tenet Healthcare shrugs off ACA headwinds with sweeping Q2 outperformance, boosts 2026 guidance
HCA Healthcare's H1 ACA volume dropoffs 'almost one for one' shifted to uninsurance
UnitedHealthcare exec says 'ineffective' No Surprises Act IDR process demands reform

Elevated medical costs and policy turmoil continued to affect the financial performance of payers and providers in the second quarter. Providers are still feeling the sting of fluctuations in ACA plan enrollment, while payers pointed to the No Surprises Act&rsquo;s arbitration process as a major challenge.
Fierce Healthcare editor Dave Muoio and senior writer Paige Minemyer sit down for another deep dive into the biggest trends emerging from second-quarter earnings calls.
To learn more about the topics in this episode:&nbsp;
<ul>
<li><a href="https://www.fiercehealthcare.com/payers/payer-2026-q2-earnings-unitedhealth-cvs-cigna-elevance-health" data-processed-url="true">Insurers see positive results in managing health costs in Q2</a></li>
<li><a href="https://www.fiercehealthcare.com/providers/ardent-health-offsets-q2-volume-stumble-tightening-costs-renegotiating-contracts" data-processed-url="true">Ardent Health offsets Q2 volume stumble by tightening costs, renegotiating contracts</a></li>
<li><a href="https://www.fiercehealthcare.com/payers/cvs-raises-guidance-it-posts-3b-profit-106b-revenue-q2" data-processed-url="true">CVS enhances supports for patients taking GLP-1s</a></li>
<li><a href="https://www.fiercehealthcare.com/providers/universal-health-services-tops-q2-expectations-dials-back-full-year-earnings" data-processed-url="true">Universal Health Services tops Q2 expectations, but dials back full-year earnings</a></li>
<li><a href="https://www.fiercehealthcare.com/providers/tenet-healthcare-shrugs-aca-headwinds-sweeping-q2-outperformance-boosts-2026-guidance" data-processed-url="true">Tenet Healthcare shrugs off ACA headwinds with sweeping Q2 outperformance, boosts 2026 guidance</a></li>
<li><a href="https://www.fiercehealthcare.com/finance/hca-healthcare-reports-203b-q2-revenue-amid-aca-coverage-disruptions" data-processed-url="true">HCA Healthcare's H1 ACA volume dropoffs 'almost one for one' shifted to uninsurance</a></li>
<li><a href="https://www.fiercehealthcare.com/payers/unitedhealthcare-exec-says-ineffective-no-surprises-act-idr-process-demands-reform" data-processed-url="true">UnitedHealthcare exec says 'ineffective' No Surprises Act IDR process demands reform</a></li>
</ul>

The biggest payer and provider trends from Q2

Multiple sclerosis is a chronic autoimmune disease that requires proactive early intervention and treatment to achieve the best long-term outcomes. But recommendations for MS patients who are pregnant can be murky.

Driven by knowledge gaps and concerns about the effects of disease-modifying therapies on the fetus, providers have often advised MS patients not to become pregnant. However, emerging research shows that patients can safely continue certain MS medications during pregnancy.

Katrina Bawden, a family nurse practitioner and MS-certified nurse at Rocky Mountain MS Clinic, is working to fill the research gap by tracking pregnancies among women with MS. She discusses the outcomes she is seeing with Senior Writer Anastassia Gliadkovskaya.

To learn more about the topics in this episode: 
'We want to feel heard': Jamie-Lynn Sigler on how pharmas can better serve patients
As Roche eyes busy 2026, Vabysmo undershoots targets and Tecentriq fails early lung cancer study 
Fewer than 1% of clinical trials in the US include pregnant patients, study finds

Multiple sclerosis is a chronic autoimmune disease that requires proactive early intervention and treatment to achieve the best long-term outcomes. But recommendations for MS patients who are pregnant can be murky.
Driven by knowledge gaps and concerns about the effects of disease-modifying therapies on the fetus, providers have often advised MS patients not to become pregnant. However, <a href="https://www.medscape.com/viewarticle/evidence-shifts-perspective-multiple-sclerosis-drug-use-2025a1000fex?form=fpf">emerging research</a> shows that patients can safely continue certain MS medications during pregnancy.
Katrina Bawden, a family nurse practitioner and MS-certified nurse at Rocky Mountain MS Clinic, is working to fill the research gap by tracking pregnancies among women with MS. She discusses the outcomes she is seeing with Senior Writer Anastassia Gliadkovskaya.
To learn more about the topics in this episode:&nbsp;
<ul>
<li><a href="https://www.fiercepharma.com/marketing/we-want-feel-heard-jamie-lynn-sigler-how-pharmas-can-better-serve-patients" data-processed-url="true">'We want to feel heard': Jamie-Lynn Sigler on how pharmas can better serve patients</a></li>
<li><a href="https://www.fiercepharma.com/pharma/roche-eyes-busy-2026-vabysmo-undershoots-targets-tecentriq-fails-early-lung-cancer-study" data-processed-url="true">As Roche eyes busy 2026, Vabysmo undershoots targets and Tecentriq fails early lung cancer study</a>&nbsp;</li>
<li><a href="https://www.fiercebiotech.com/cro/fewer-1-clinical-trials-us-include-pregnant-patients-study-finds" data-processed-url="true">Fewer than 1% of clinical trials in the US include pregnant patients, study finds</a></li>
</ul>

The Fierce 15 of 2024

In 1 playlist(s)

Podnosis

Social links

Follow podcast

Recent clips